Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BLU-5937
BLU-5937
Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis
Endpoints
Mon, 12/13/21 - 11:06 am
Bellus Health
chronic cough
Merck
BLU-5937
gefapixant
Bellus hit with a setback as its PhII chronic cough drug flops on all 4 doses -- shares cremated on Wall Street
Endpoints
Mon, 07/6/20 - 10:24 am
Bellus Health
BLU-5937
clinical trials
chronic cough